Physician profile
Ryan C Dougherty
NPI 1891089348
$259.52
in general payments reported to CMS, 2019-2025
9 companies · $16.01 in 2025
The $16.01 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.71 · 2020: $31.64 · 2022: $33.82 · 2024: $92.34 · 2025: $16.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $63.35 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $63.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $63.54 | 2019-2024 | Ozempic, Rybelsus |
| Becton, Dickinson and Company | $45.00 | 2024 | Bd Introsyte |
| Endo Pharmaceuticals INC. | $33.82 | 2022 | |
| Amgen INC. | $33.69 | 2019-2020 | |
| Abbvie INC. | $28.13 | 2024 | |
| Merck Sharp & Dohme LLC | $16.01 | 2025 | Vaxelis, Gardasil 9, Capvaxive |
| Eisai INC. | $13.42 | 2019 | |
| Lilly USA, LLC | $13.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.